Trial size, HIV pre-exposure prophylaxis, and breastfeeding - Authors' reply.
Biostatistics Unit, Medical Research Council of South Africa, Cape Town, South Africa.
Carl
C
Lombard
Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Simon
S
Cousens
Centre for International Health, University of Bergen, Bergen, Norway.
Thorkild
T
Tylleskär
INSERM U 1058, University Montpellier and CHU Montpellier, Montpellier 34090, France. Electronic address: p-van_de_perre@chu-montpellier.fr.
Philippe
P
Van de Perre
INSERM U 1058, University Montpellier and CHU Montpellier, Montpellier 34090, France.
Nicolas
N
Nagot
D019380:Anti-HIV Agents / Q000008:administration & dosage*; D001942:Breast Feeding; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D015497:HIV-1; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D065129:Pre-Exposure Prophylaxis / Q000379:methods*
D019380:Anti-HIV Agents